查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1464966

脑肿瘤和脊髓癌市场：按肿瘤类型、治疗方法和最终用户划分 - 全球预测 2024-2030

Brain & Spinal Cord Cancer Market by Tumor Type (Glioblastoma, Meningioma, Pituitary Tumors), Treatment (Diagnosis, Therapeutics), End-users - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年脑瘤和脊髓癌市场规模为37.7亿美元，2024年达39.8亿美元，预计2030年将达到55.9亿美元，复合年增长率为5.75%。

脑癌和脊髓癌是当恶性（癌）细胞在脑或脊髓组织中生长时发生的中枢神经系统癌症。这些癌症会损害这些区域控制的重要功能，例如肌肉控制、感觉、记忆和其他认知能力。脑癌和脊髓癌的治疗计划根据每个人的具体情况量身定制，可能包括手术、放射线治疗、化疗、标靶治疗或这些治疗的组合。该市场的应用涵盖各个医学领域，包括神经肿瘤学、神经外科、放射学和安宁疗护。最终使用者通常是需要诊断、治疗和支持性护理服务的患者，以及医院、诊所和专门癌症治疗中心等医疗机构。影响脑癌和脊髓癌治疗需求的因素包括医疗技术的进步、脑癌和脊髓癌盛行率的上升、医疗基础设施投资的增加以及对这些疾病的认识。然而，市场面临某些挑战，包括治疗成本上升、获得先进医疗设施的机会有限，以及对脑癌和脊髓癌复杂性的担忧。另一方面，将人工智慧和机器学习引入诊断过程，以及人们对基于基因图谱的个人化医疗的日益偏好，正在为脑肿瘤和脊椎癌市场创造潜在机会。

主要市场统计
基准年[2023] 37.7亿美元
预测年份 [2024] 39.8亿美元
预测年份 [2030] 55.9亿美元
复合年增长率（%） 5.75%

治疗

诊断是癌症治疗的基石，准确的识别对于有效的治疗策略至关重要。对于脑癌和脊髓癌，主要使用诊断影像和切片检查。 电脑断层扫描、MRI 和正子断层扫描 (PET) 扫描等先进影像方式在诊断脑癌和脊髓癌方面发挥重要作用。切片检查，包括针吸活检和开放切片检查，透过分析组织样本来确认癌症的存在。脑癌和脊髓癌的治疗采用多方面的治疗方法，包括手术、放射线治疗、化疗和标靶治疗。手术通常是切除肿瘤的首选治疗方法。另一种重要的治疗方法是放射线治疗，它使用高能量射线来破坏癌细胞。化疗使用药物杀死癌细胞，通常与其他治疗方法结合。标靶治疗是一种新型癌症治疗方法，特异性针对癌细胞而不伤害正常细胞。根据肿瘤类型、分期和患者健康状况，治疗方法选择是高度个人化的。对于局部肿瘤，优选手术或放射线治疗来切除或缩小肿瘤。相反，化疗和标靶治疗有利于治疗全身性疾病和无法手术的肿瘤。

最终用户

门诊手术中心 (ASC) 在脑癌和脊髓癌的治疗中变得越来越重要，为患者提供恢復时间短的微创手术选择。对于患者病情稳定且手术复杂程度为轻度至中度的病例，这些中心是首选。这些中心强调成本效益、病人便利性和快速出院。诊断中心在脑肿瘤和脊髓癌的早期诊断中发挥重要作用。这些设施配备了先进的诊断影像技术，包括 MRI、 电脑断层扫描和 PET 扫描，这对于准确的诊断和治疗计划至关重要。患者和医疗保健提供者通常更喜欢提供先进技术、快速诊断时间和优质影像服务的专业诊断中心。医院和诊所是脑癌和脊髓癌患者最全面的医疗保健机构，提供从诊断到手术、放射线治疗和化疗等高级治疗方法的广泛服务。这些医院因其交通方便、多学科团队以及处理复杂病例和紧急情况的能力而受到青睐。儘管这三个领域在脑癌和脊髓癌患者的持续照护中都发挥着重要作用，但他们基于需求的偏好存在明显差异。由于 ASC 的效率和成本效益，它是不太复杂的手术需求的首选。诊断中心对于使用先进的影像技术进行早期、准确的诊断至关重要。然而，医院和诊所处理最复杂和紧急的病例，提供最广泛的服务，并拥有综合多学科护理团队的优势。

区域洞察

美洲，特别是美国和加拿大，正在对研发进行大量投资，以推进脑癌和脊髓癌的治疗。高昂的医疗成本以及大型医疗机构和生物技术公司的存在正在推动先进的研究倡议，包括精准医学和新型疗法。在南美洲，由于医疗成本上升、癌症发病率增加以及医疗基础设施改善缓慢，巴西和阿根廷在脑癌和脊髓癌的治疗方面进展缓慢。欧盟国家拥有强大的医疗基础设施，多项癌症研究和早期检测倡议正在进行中。公共和私营部门对医学研究的资助不断增加，正在带来重大突破。该地区的患者受益于全民健康保险体系并获得先进的治疗。中东和非洲地区面临独特的挑战，包括医疗基础设施的变化和可近性问题。重点逐渐转向改善医疗设施和癌症治疗中心，政府和非政府组织扮演重要角色。在中国、日本和印度等国家经济成长的推动下，亚太地区正见证医疗保健产业的快速转型。这些国家的医疗支出正在快速成长，并且处于癌症治疗技术创新的前沿。消费者对优质癌症照护的认识和需求很高，导致政府和私人对医疗基础设施和研究计画的投资增加。

FPNV定位矩阵

FPNV定位矩阵对于评估脑肿瘤和脊椎癌市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对脑肿瘤和脊椎癌市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告对以下几个方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.脑肿瘤/脊髓癌市场的市场规模和预测是多少？

2.在脑肿瘤和脊髓癌市场的预测期内，有哪些产品、细分市场、应用和领域需要考虑投资？

3.脑肿瘤/脊髓癌市场的技术趋势和法规结构是什么？

4.脑肿瘤/脊髓癌市场主要厂商的市场占有率是多少？

5.进入脑肿瘤/脊髓癌市场的合适型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球脑和脊髓肿瘤的发生率增加
      • 随着人们对这些疾病的认识不断提高，对医疗保健基础设施的投资也增加
      • 政府继续努力进行癌症研究和早期检测
    • 抑制因素
      • 脑癌和脊髓癌的治疗费用很高，并且获得先进医疗设施的机会有限。
    • 机会
      • 将人工智慧和机器学习纳入诊断过程
      • 人们对基于基因图谱的个人化医疗越来越感兴趣
    • 任务
      • 对脑癌和脊髓癌复杂性的担忧
  • 市场区隔分析

第 5 章 2.1。

第 5 章 2.2。

  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章依肿瘤类型分類的脑肿瘤/脊髓癌市场

  • 神经胶母细胞瘤
  • 脑膜瘤
  • 脑下垂体瘤

第七章依治疗分類的脑肿瘤/脊髓癌市场

  • 诊断
  • 治疗药物

第八章脑肿瘤/脊髓癌市场：依最终用户分类

  • 门诊手术中心
  • 诊断中心
  • 医院/诊所

第九章北美和南美脑肿瘤和脊髓癌市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区脑肿瘤与脊髓癌市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的脑肿瘤和脊髓癌市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Diaconos 脑肿瘤疫苗获得 FDA 孤儿药称号
    • 诺华公司的 Tafinlar + Mekinist 已获得 FDA核准用于患有 BRAF V600E 低恶性神经胶质瘤（最常见的儿童脑瘤）的儿童患者。
  • 战略分析和建议

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-9E71DF483B96

[187 Pages Report] The Brain & Spinal Cord Cancer Market size was estimated at USD 3.77 billion in 2023 and expected to reach USD 3.98 billion in 2024, at a CAGR 5.75% to reach USD 5.59 billion by 2030.

Brain and spinal cord cancers are types of central nervous system cancers that occur when malignant (cancer) cells grow in the brain or spinal cord tissue. These cancers can disrupt the vital functions controlled by these areas, including muscle control, sensation, memory, and other cognitive abilities. Treatment plans for brain and spinal cord cancers are tailored to each individual's specific condition and may include surgery, radiation therapy, chemotherapy, targeted therapy, or a combination of these. This market's applications span across various medical fields, including neuro-oncology, neurosurgery, radiology, and palliative care. End-users are typically healthcare facilities such as hospitals, clinics, and specialized cancer treatment centers, besides patients requiring diagnostic, therapeutic, and supportive care services. Factors influencing the need for brain and spinal cord cancer treatment include advancements in medical technology, rising prevalence of brain and spinal cord cancers, increased investment in healthcare infrastructure, and awareness about these conditions. However, the market faces certain challenges, such as high treatment costs, limited accessibility to advanced healthcare facilities, and concerns associated with the complex nature of brain and spinal cord cancers. On the other hand, the incorporation of AI and machine learning in diagnostic processes and increasing preference for personalized medicine based on genetic profile present potential opportunities for the brain and spinal cord cancers market.

KEY MARKET STATISTICS
Base Year [2023] USD 3.77 billion
Estimated Year [2024] USD 3.98 billion
Forecast Year [2030] USD 5.59 billion
CAGR (%) 5.75%

Treatment:

Diagnosis forms the cornerstone of cancer treatment, with accurate identification pivotal for effective management strategies. For brain and spinal cord cancers, diagnosis primarily involves imaging techniques and biopsy procedures. Advanced imaging methods, including CT scans, MRI, and Positron Emission Tomography (PET) scans, play a vital role in diagnosing brain and spinal cord cancers. Biopsies, including needle biopsy and open biopsy, are employed to confirm the presence of cancer through tissue sample analysis. The therapy of brain and spinal cord cancers involves a multi-faceted therapeutic approach, including surgery, radiation therapy, chemotherapy, and targeted therapy. Surgery is often the first line of treatment aimed at tumor removal. Another critical treatment modality is radiation therapy, which employs high-energy rays to destroy cancer cells. Chemotherapy utilizes drugs to kill cancer cells and is often used in conjunction with other treatments. Targeted therapy represents a newer class of cancer treatment that specifically targets cancerous cells without harming normal ones. The selection of a therapeutic approach is highly individualized, based on tumor type, stage, and patient health. Surgery and radiation therapy are preferred for localized tumors to remove or decrease tumor size. In contrast, chemotherapy and targeted therapy are beneficial for managing systemic disease or tumors that are inoperable.

End-users:

Ambulatory surgical centers (ASCs) have become increasingly important in the cure of brain and spinal cord cancer, offering patients minimally invasive surgery options with shorter recovery times. These centers are preferred for cases where the patient's condition is stable and the complexity of the surgery is low to moderate. They emphasize cost-effectiveness, patient convenience, and quick discharge. Diagnostic centers play a critical role in the initial stages of diagnosing brain and spinal cord cancer. These facilities are equipped with advanced imaging technologies including MRI, CT scans, and PET scans, vital for accurate diagnosis and treatment planning. Patients and healthcare providers often prefer specialized diagnostic centers for their advanced technology, quick turnaround times, and high-quality imaging services. Hospitals and clinics are the most comprehensive providers for brain and spinal cord cancer patients, offering various services from diagnosis to advanced treatment options, including surgery, radiation therapy, and chemotherapy. They are preferred for their accessibility, multidisciplinary teams, and ability to handle complex cases and emergencies. While all three segments play vital roles in the continuum of care for brain and spinal cord cancer patients, there are distinct differences in their need-based preferences. ASCs are preferred for their efficiency and cost-effectiveness for less complex surgical needs. Diagnostic centers are critical for early and accurate diagnosis, leveraging advanced imaging technologies. Hospitals and clinics, however, offer the broadest range of services, catering to the most complex and emergent cases, and have the advantage of integrated, multidisciplinary care teams.

Regional Insights

In the Americas, particularly in the United States and Canada, significant investments in research and development have been made to advance the treatment of brain and spinal cord cancers. High healthcare expenses and the presence of major healthcare institutions and biotech firms have propelled advanced research initiatives, including precision medicine and novel therapeutics. In South America, Brazil and Argentina are witnessing moderate development in the treatment of the brain and spinal cord cancer market due to rising healthcare expenditure, increasing incidence of cancer, and gradual improvements in healthcare infrastructure. The EU countries boast a robust healthcare infrastructure and several ongoing initiatives for cancer research and early detection. Increased funding from both public and private sectors towards healthcare research has led to significant breakthroughs. Patients in this region benefit from universal healthcare systems, influencing their ability to access advanced treatments. The Middle East and Africa region encounters unique challenges, including variable healthcare infrastructure and accessibility issues. The focus is gradually shifting towards improving healthcare facilities and cancer care centers, with several governments and NGOs playing a pivotal role. The APAC region is witnessing a rapid transformation in the healthcare sector, driven by growing economies such as China, Japan, and India. These countries have seen a surge in healthcare spending and are at the forefront of technological innovation in cancer treatment. Consumer awareness and demand for quality cancer care are high, leading to greater government and private investment in healthcare infrastructure and research initiatives.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Brain & Spinal Cord Cancer Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Brain & Spinal Cord Cancer Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Brain & Spinal Cord Cancer Market, highlighting leading vendors and their innovative profiles. These include Amgen Inc., Bayer AG, bluebird bio, Inc., Bristol Myers Squibb Company, Dr. Reddy's Laboratories Ltd., Eisai Inc., F. Hoffmann-La Roche Ltd., Genentech, Inc., GlaxoSmithKline PLC, Illumina, Inc., Johnson & Johnson Services, Inc, Merck & Co., Inc., Nektar Therapeutics, Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals, Inc., Shimadzu Corporation, Siemens Healthineers, Teva Pharmaceutical Industries Ltd., and Y-mAbs Therapeutics A/S.

Market Segmentation & Coverage

This research report categorizes the Brain & Spinal Cord Cancer Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Tumor Type
    • Glioblastoma
    • Meningioma
    • Pituitary Tumors
  • Treatment
    • Diagnosis
      • Cerebral Arteriogram
      • CT Scan
      • EEG
      • Lumbar Puncture
      • Molecular Testing
      • MRI
      • PET-CT Scan
      • Tissue Sampling
    • Therapeutics
      • Chemotherapy
      • Immunotherapy
      • Radiation Therapy
      • Surgery
      • Targeted Therapy
  • End-users
    • Ambulatory Surgical Centers
    • Diagnostic Centers
    • Hospital & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Brain & Spinal Cord Cancer Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Brain & Spinal Cord Cancer Market?

3. What are the technology trends and regulatory frameworks in the Brain & Spinal Cord Cancer Market?

4. What is the market share of the leading vendors in the Brain & Spinal Cord Cancer Market?

5. Which modes and strategic moves are suitable for entering the Brain & Spinal Cord Cancer Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of brain and spinal cord cancers globally
      • 5.1.1.2. Increased investment in healthcare infrastructure with growing awareness about these conditions
      • 5.1.1.3. Ongoing government initiatives aimed at cancer research and early detection
    • 5.1.2. Restraints
      • 5.1.2.1. High treatment costs and limited accessibility to advanced healthcare facilities for brain and spinal cord cancer
    • 5.1.3. Opportunities
      • 5.1.3.1. Incorporation of AI and machine learning in diagnostic processes
      • 5.1.3.2. Increasing preference for personalized medicine based on genetic profile
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with the complex nature of brain and spinal cord cancers
  • 5.2. Market Segmentation Analysis

5.2.1. Treatment:

5.2.2. End-users:

  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Brain & Spinal Cord Cancer Market, by Tumor Type

  • 6.1. Introduction
  • 6.2. Glioblastoma
  • 6.3. Meningioma
  • 6.4. Pituitary Tumors

7. Brain & Spinal Cord Cancer Market, by Treatment

  • 7.1. Introduction
  • 7.2. Diagnosis
  • 7.3. Therapeutics

8. Brain & Spinal Cord Cancer Market, by End-users

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Diagnostic Centers
  • 8.4. Hospital & Clinics

9. Americas Brain & Spinal Cord Cancer Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Brain & Spinal Cord Cancer Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Brain & Spinal Cord Cancer Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Diakonos' brain tumor vaccine receives FDA's orphan drug designation
    • 12.3.2. Novartis Tafinlar + Mekinist approved by FDA for pediatric patients with BRAF V600E low-grade glioma, the most common pediatric brain cancer
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. BRAIN & SPINAL CORD CANCER MARKET RESEARCH PROCESS
  • FIGURE 2. BRAIN & SPINAL CORD CANCER MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. BRAIN & SPINAL CORD CANCER MARKET DYNAMICS
  • FIGURE 7. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. BRAIN & SPINAL CORD CANCER MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. BRAIN & SPINAL CORD CANCER MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BRAIN & SPINAL CORD CANCER MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY GLIOBLASTOMA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY GLIOBLASTOMA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY MENINGIOMA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY MENINGIOMA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY PITUITARY TUMORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY PITUITARY TUMORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CEREBRAL ARTERIOGRAM, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CEREBRAL ARTERIOGRAM, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CT SCAN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CT SCAN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY EEG, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY EEG, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY LUMBAR PUNCTURE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY LUMBAR PUNCTURE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY MOLECULAR TESTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY MOLECULAR TESTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY MRI, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY MRI, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY PET-CT SCAN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY PET-CT SCAN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TISSUE SAMPLING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TISSUE SAMPLING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY SURGERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY SURGERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 71. ARGENTINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 72. ARGENTINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 73. ARGENTINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 74. ARGENTINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 77. ARGENTINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 78. ARGENTINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 79. ARGENTINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 80. ARGENTINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 81. BRAZIL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 82. BRAZIL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 83. BRAZIL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 84. BRAZIL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 85. BRAZIL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 86. BRAZIL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 87. BRAZIL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 88. BRAZIL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 89. BRAZIL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 90. BRAZIL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 91. CANADA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 92. CANADA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 93. CANADA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 94. CANADA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 95. CANADA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 96. CANADA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 97. CANADA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 98. CANADA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 99. CANADA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 100. CANADA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 101. MEXICO BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 102. MEXICO BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 103. MEXICO BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 104. MEXICO BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 105. MEXICO BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 106. MEXICO BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 107. MEXICO BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 108. MEXICO BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 109. MEXICO BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 110. MEXICO BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 111. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 112. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 113. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 114. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 115. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 116. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 117. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 118. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 119. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 120. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 121. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 122. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 135. AUSTRALIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 136. AUSTRALIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 137. AUSTRALIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 138. AUSTRALIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 139. AUSTRALIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 140. AUSTRALIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 141. AUSTRALIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 142. AUSTRALIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 143. AUSTRALIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 144. AUSTRALIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 145. CHINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 146. CHINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 147. CHINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 148. CHINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 149. CHINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 150. CHINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 151. CHINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 152. CHINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 153. CHINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 154. CHINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 155. INDIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 156. INDIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 157. INDIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 158. INDIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 159. INDIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 160. INDIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 161. INDIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 162. INDIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 163. INDIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 164. INDIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 165. INDONESIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 166. INDONESIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 167. INDONESIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 168. INDONESIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 169. INDONESIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 170. INDONESIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 171. INDONESIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 172. INDONESIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 173. INDONESIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 174. INDONESIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 175. JAPAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 176. JAPAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 177. JAPAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 178. JAPAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 179. JAPAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 180. JAPAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 181. JAPAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 182. JAPAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 183. JAPAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 184. JAPAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 185. MALAYSIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 186. MALAYSIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 187. MALAYSIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 188. MALAYSIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 189. MALAYSIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 190. MALAYSIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 191. MALAYSIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 192. MALAYSIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 193. MALAYSIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 194. MALAYSIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 195. PHILIPPINES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 196. PHILIPPINES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 197. PHILIPPINES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 198. PHILIPPINES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 199. PHILIPPINES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 200. PHILIPPINES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 201. PHILIPPINES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 202. PHILIPPINES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 203. PHILIPPINES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 204. PHILIPPINES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 205. SINGAPORE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 206. SINGAPORE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 207. SINGAPORE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 208. SINGAPORE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 209. SINGAPORE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 210. SINGAPORE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 211. SINGAPORE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 212. SINGAPORE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 213. SINGAPORE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 214. SINGAPORE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 215. SOUTH KOREA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 216. SOUTH KOREA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 217. SOUTH KOREA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 218. SOUTH KOREA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 219. SOUTH KOREA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 220. SOUTH KOREA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 221. SOUTH KOREA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 222. SOUTH KOREA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 223. SOUTH KOREA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 224. SOUTH KOREA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 225. TAIWAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 226. TAIWAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 227. TAIWAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 228. TAIWAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 229. TAIWAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 230. TAIWAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 231. TAIWAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 232. TAIWAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 233. TAIWAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 234. TAIWAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 235. THAILAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 236. THAILAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 237. THAILAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 238. THAILAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 239. THAILAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 240. THAILAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 241. THAILAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 242. THAILAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 243. THAILAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 244. THAILAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 245. VIETNAM BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 246. VIETNAM BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 247. VIETNAM BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 248. VIETNAM BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 249. VIETNAM BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 250. VIETNAM BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 251. VIETNAM BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 252. VIETNAM BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 253. VIETNAM BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 254. VIETNAM BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 267. DENMARK BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 268. DENMARK BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 269. DENMARK BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 270. DENMARK BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 271. DENMARK BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 272. DENMARK BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 273. DENMARK BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 274. DENMARK BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 275. DENMARK BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 276. DENMARK BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 277. EGYPT BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 278. EGYPT BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 279. EGYPT BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 280. EGYPT BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 281. EGYPT BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 282. EGYPT BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 283. EGYPT BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 284. EGYPT BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 285. EGYPT BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 286. EGYPT BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 287. FINLAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 288. FINLAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 289. FINLAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 290. FINLAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 291. FINLAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 292. FINLAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 293. FINLAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 294. FINLAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 295. FINLAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 296. FINLAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 297. FRANCE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 298. FRANCE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 299. FRANCE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 300. FRANCE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 301. FRANCE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 302. FRANCE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 303. FRANCE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 304. FRANCE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 305. FRANCE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 306. FRANCE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 307. GERMANY BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 308. GERMANY BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 309. GERMANY BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 310. GERMANY BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 311. GERMANY BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 312. GERMANY BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 313. GERMANY BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 314. GERMANY BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 315. GERMANY BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 316. GERMANY BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 317. ISRAEL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 318. ISRAEL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 319. ISRAEL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 320. ISRAEL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 321. ISRAEL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 322. ISRAEL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 323. ISRAEL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 324. ISRAEL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 325. ISRAEL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 326. ISRAEL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 327. ITALY BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 328. ITALY BRAIN & SPINAL CORD CANC